company background image
954 logo

Changmao Biochemical Engineering SEHK:954 Stock Report

Last Price

HK$0.38

Market Cap

HK$198.6m

7D

-1.3%

1Y

-60.5%

Updated

27 Mar, 2024

Data

Company Financials

Changmao Biochemical Engineering Company Limited

SEHK:954 Stock Report

Market Cap: HK$198.6m

954 Stock Overview

Changmao Biochemical Engineering Company Limited, together with its subsidiaries, produces and sells organic acids for food additive, chemical, and pharmaceutical industries in Mainland China, Europe, Asia Pacific, the United States, and internationally.

954 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends3/6

Changmao Biochemical Engineering Company Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Changmao Biochemical Engineering
Historical stock prices
Current Share PriceHK$0.38
52 Week HighHK$1.15
52 Week LowHK$0.36
Beta0.66
1 Month Change-27.88%
3 Month Change-34.21%
1 Year Change-60.53%
3 Year Change-44.85%
5 Year Change-59.24%
Change since IPO-51.30%

Recent News & Updates

Recent updates

Investors Will Want Changmao Biochemical Engineering's (HKG:954) Growth In ROCE To Persist

Aug 02
Investors Will Want Changmao Biochemical Engineering's (HKG:954) Growth In ROCE To Persist

Returns On Capital At Changmao Biochemical Engineering (HKG:954) Have Stalled

Nov 18
Returns On Capital At Changmao Biochemical Engineering (HKG:954) Have Stalled

We Believe Changmao Biochemical Engineering's (HKG:954) Earnings Are A Poor Guide For Its Profitability

Apr 28
We Believe Changmao Biochemical Engineering's (HKG:954) Earnings Are A Poor Guide For Its Profitability

Changmao Biochemical Engineering (HKG:954) Will Be Looking To Turn Around Its Returns

Aug 03
Changmao Biochemical Engineering (HKG:954) Will Be Looking To Turn Around Its Returns

Changmao Biochemical Engineering (HKG:954) May Have Issues Allocating Its Capital

May 04
Changmao Biochemical Engineering (HKG:954) May Have Issues Allocating Its Capital

Tread With Caution Around Changmao Biochemical Engineering Company Limited's (HKG:954) 8.8% Dividend Yield

Feb 23
Tread With Caution Around Changmao Biochemical Engineering Company Limited's (HKG:954) 8.8% Dividend Yield

Will Changmao Biochemical Engineering (HKG:954) Multiply In Value Going Forward?

Jan 26
Will Changmao Biochemical Engineering (HKG:954) Multiply In Value Going Forward?

A Quick Analysis On Changmao Biochemical Engineering's (HKG:954) CEO Salary

Dec 02
A Quick Analysis On Changmao Biochemical Engineering's (HKG:954) CEO Salary

Shareholder Returns

954HK ChemicalsHK Market
7D-1.3%-3.0%-0.6%
1Y-60.5%-20.3%-14.0%

Return vs Industry: 954 underperformed the Hong Kong Chemicals industry which returned -18.7% over the past year.

Return vs Market: 954 underperformed the Hong Kong Market which returned -12.7% over the past year.

Price Volatility

Is 954's price volatile compared to industry and market?
954 volatility
954 Average Weekly Movement7.8%
Chemicals Industry Average Movement5.6%
Market Average Movement7.3%
10% most volatile stocks in HK Market14.6%
10% least volatile stocks in HK Market3.7%

Stable Share Price: 954's share price has been volatile over the past 3 months.

Volatility Over Time: 954's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1992574Chun Panhttps://www.cmbec.com.hk

Changmao Biochemical Engineering Company Limited, together with its subsidiaries, produces and sells organic acids for food additive, chemical, and pharmaceutical industries in Mainland China, Europe, Asia Pacific, the United States, and internationally. The company’s products include fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame that are used as food additives, pharmaceutical adjuvant, and active pharmaceutical ingredient, etc. It is also involved in the research and development of medicine and nutraceutical products; production and sale of food additives; trading of organic acids; and property holding activities. The company was founded in 1992 and is headquartered in Changzhou, the People's Republic of China.

Changmao Biochemical Engineering Company Limited Fundamentals Summary

How do Changmao Biochemical Engineering's earnings and revenue compare to its market cap?
954 fundamental statistics
Market capHK$198.64m
Earnings (TTM)-HK$93.17m
Revenue (TTM)HK$689.72m

0.3x

P/S Ratio

-2.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
954 income statement (TTM)
RevenueCN¥637.08m
Cost of RevenueCN¥611.27m
Gross ProfitCN¥25.81m
Other ExpensesCN¥111.87m
Earnings-CN¥86.06m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.16
Gross Margin4.05%
Net Profit Margin-13.51%
Debt/Equity Ratio75.6%

How did 954 perform over the long term?

See historical performance and comparison

Dividends

22.2%

Current Dividend Yield

91%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.